Indian Supreme Court to Hear Final Arguments in Novartis Patent Case
India’s Supreme Court is set to hear final arguments Sept. 11 in a case between Novartis and the Indian patent office that could have repercussions for the country’s controversial intellectual property (IP) laws and vast generic drug industry.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.